Emerging antifungal compounds and strategies targeting Candida species: a mini-review of advances from 2010 to 2025.
INTRODUCTION The global rise of invasive and drug-resistant Candida infections has intensified the need for antifungal agents with novel mechanisms of action. Conventional classes of systemic drugs face limitations due to toxicity, pharmacokinetic constraints, and increasing fungi resistance, particularly among C. glab...